Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Simvastatin is a biosimilar HMG-CoA reductase inhibitor primarily used to lower lipid levels and reduce the risk of cardiovascular events such as myocardial infarction and stroke. Structurally, simvastatin contains a lactone ring and is administered as an inactive prodrug, which is converted in the body to its active beta-hydroxy acid form. The gene location for simvastatin biosimilars is not directly applicable as it is a synthetic compound rather than a biological product derived from genetic material. Functionally, simvastatin works by inhibiting the HMG-CoA reductase enzyme, which plays a crucial role in cholesterol synthesis in the liver. Studies have evaluated the bioequivalence of simvastatin biosimilars, comparing pharmacokinetics and therapeutic efficacy to reference formulations, ensuring similar safety and effectiveness profiles.
仅用于科研。不用于诊断过程。未经明确授权不得转售。